

Encouraging objective response rate of 52.4% was seen with ifinatamab deruxtecan in heavily pretreated patients IDeate-01 phase 2 trial currently enrolling patients...


An objective response rate of 29.8% was observed with patritumab deruxtecan in heavily pretreated patients BLA submission in U.S. planned for the...


Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab with or without chemotherapy demonstrated objective response rates of 77% and 50% and disease...


Medical professionals and social organizations call for increased awareness of pneumococcal threat and strengthened preventative measures among high-risk individuals HONG KONG SAR...


HANOI, VIETNAM – Media OutReach – 9 September 2023 – President of the United States Joe Biden’s official visit to Vietnam (Sep...
SINGAPORE – Media OutReach – 9 September 2023 – BingX, a top copy trading crypto exchange, is showing signs of its strategic...


 TAIPEI,Taiwan–(BUSINESS WIRE)–TVBS, the Taiwanese broadcasting network that kicked off operations in 1993, marks its three-decade anniversary with a significant exhibition entitled...


HOBART, AUSTRALIA – Media OutReach – 8 September 2023 – Procreate announces the launch of its new animation app for iPad, Procreate...


SINGAPORE–(BUSINESS WIRE)–#insurance—AM Best has downgraded the Financial Strength Rating to B++ (Good) from A- (Excellent) and the Long-Term Issuer Credit Rating to...


The Australian-born brand beloved by Gen Z makes its U.S. debut SAN FRANCISCO–(BUSINESS WIRE)–a.k.a. Brands Holding Corp. (NYSE: AKA), a brand accelerator...


HONG KONG SAR – Media OutReach – 8 September 2023 – To help companies strengthen their electronics supply chain and reduce procurement...







